Literature DB >> 32877796

Immune checkpoint inhibitor-induced bullous pemphigoid: Towards a new class of drug-drug interaction?

Marc Pujalte-Martin1, Fanny Rocher2, Nathalie Cardot-Leccia3, Damien Giacchero4, Delphine Borchiellini5.   

Abstract

Year:  2020        PMID： 32877796     DOI： 10.1016/j.ejca.2020.07.027

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation.

Authors:  Dennis Niebel; Dagmar Wilsmann-Theis; Thomas Bieber; Mark Berneburg; Joerg Wenzel; Christine Braegelmann
Journal:  Dermatopathology (Basel)       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.